Hiromasa Kato Selected Research

Hiromasa Kato Research Topics

4	Ulcerative Colitis 12/2023 - 11/2021
3	Inflammation (Inflammations) 01/2023 - 01/2020
2	Sarcopenia 04/2024 - 12/2021
2	Muscular Atrophy (Muscle Atrophy) 04/2024 - 12/2021
2	Chronic Renal Insufficiency 01/2023 - 12/2021
1	Appendicitis 12/2023
1	Atrophy 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Secondary Hyperparathyroidism 01/2020
1	Mouth Breathing 12/2018
1	Asthma (Bronchial Asthma) 12/2018
1	Nasal Obstruction 12/2018
1	Long QT Syndrome 07/2006

3	AlbuminsIBA 12/2021 - 01/2020
2	Uremic ToxinsIBA 01/2023 - 01/2020
2	Advanced Oxidation Protein Products (AOPP)IBA 01/2023 - 12/2021
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2021 - 01/2020
1	Messenger RNA (mRNA)IBA 04/2024
1	MyostatinIBA 04/2024
1	Carbon MonoxideIBA 04/2024
1	Coffee FDA Link 12/2023
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2023
1	Vitamin A (Retinol)FDA LinkGeneric 12/2023
1	Caffeine (No Doz)FDA LinkGeneric 12/2023
1	Adenine FDA LinkGeneric 01/2023
1	Tobacco Smoke Pollution (Passive Smoking)IBA 04/2022
1	InterleukinsIBA 01/2022
1	AntioxidantsIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	AST 120IBA 01/2020
1	Kynurenic Acid (Kynurenate)IBA 01/2020
1	Sulfates (Sulfates, Inorganic)IBA 01/2020
1	CreatinineIBA 01/2020
1	indoleacetic acid (indole acetic acid)IBA 01/2020
1	Cinacalcet (Sensipar)FDA Link 01/2020
1	IndicanIBA 01/2020
1	AnkyrinsIBA 07/2006

1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2024
1	Renal Dialysis (Hemodialysis) 01/2020
1	Nephrectomy 01/2020
1	Bottle Feeding 12/2018